Published in Women's Health Weekly, December 25th, 2003
The WHI study found that an estrogen-progestin HT product increased the risk of heart attack, stroke, blood clots, breast cancer, gallbladder disease, and dementia.
Between January and March 2003, about 6 months after publication of the initial WHI study results, researchers at Kaiser Permanente of Northern California and the University of California, San Francisco, surveyed 670 women, ages 50 to 69,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.